THERMUCNA · Thermoresponsive and mucoadhesive nanogels for intramammary administration of antimicrobial compounds to be employed in bovine mastitis treatment
„Хоризонт 2020“ — Действия „Мария Склодовска-Кюри“
- Период
- 2021-03-01 → 2023-03-15
- Финансиране от ЕС
- 172 932 €
- Участници
- 1
- Схема
- MSCA-IF
Линиите свързват координатора с партньорите.
Накратко на български
Интелигентни наногелове за доставка на антимикробни вещества, като низин и цефтиофур, се тестват за лечение на мастит при кравите. Те помагат за оптимизиране на лекарствата и намаляване на бактериалната резистентност, което е важно за млечната индустрия.
Кратко обяснение, генерирано от езиков модел по текста на CORDIS. Оригиналът е по-долу.
Резултати накратко
Thermoresponsive and mucoadhesive nanogels for intramammary administration of antimicrobial compounds to be employed in bovine mastitis treatment
Dairy activity is vital for the European economy, producing almost a quarter of the world's available milk. Bovine mastitis (BM) is a widespread disease that affects dairy cows and causes significant economic losses in the industry worldwide. The current method of controlling BM is through antibiotic therapies. However, these treatments are often ineffective due to acquired drug resistance and the survival strategies of bacteria. In order to combat this issue, new therapeutic approaches are needed. That's why this research project proposes using smart nanogels (NGs) to deliver antimicrobial agents directly into the bovine udder for BM prophylactic treatment. The overall goal of this project is to synthesize a library of NGs that can effectively encapsulate antimicrobial cargos and have tissue-adhesive capabilities to increase their residence time in the bovine udder. NGs are also expected to (i) trigger cargo release upon the infection environment, (ii) ability to promote internalization into host cells to kill intracellular bacteria, and (iii)the ability to avoid bacterial biofilm formation. By conferring at least one of these features, we expect to develop a novel therapy that effectively reduces bacterial resistant development and optimizes antimicrobial use. During the project, pH-sensitive thermoresponsive NGs were developed. Various monomers and monomer ratios were evaluated to identify the most efficient NGs that respond specifically to an infection environment. Nisin and ceftiofurwere chosen as antimicrobial cargos, which were successfully encapsulated inside the NGs. Also, many efforts were made to set up relevant in vitro models to test the performance of all synthesized formulations. As a general conclusion of this project, smart NGs can be used to specifically release antimicrobials under infection conditions. This approach can reduce the exposure of host animals to antimicrobials and potentially avoid the development of antimicrobial resistance. It's important to note that this strategy has not been explored yet in bovine intramammary infections, which highlights the novelty of our research findings.
Текст от CORDIS, на английски · Данни: CORDIS, © Европейски съюз
Цел на проекта
Bovine mastitis (BM) is the most prevalent disease that affects dairy cows in many countries and it is the most important cause of economic losses in the dairy industry worldwide. The dairy activity is very important for the European economy, producing nearly a quarter of the world’s available milk. Currently, BM control consists mainly of antibiotic therapies. However, they usually cannot eradicate the infection due to acquired drug resistance and survival strategies of bacteria. The mechanisms developed by pathogens are intracellular and biofilm lifestyles that allow them to persist in the mammary gland protected from antibiotic therapies and host immune response. So new therapeutic approaches are needed. The present research project proposes the employment of smart nanogels (NGs) for antimicrobial delivery into mammary gland for BM treatment. The synthesized NGs will present: (i) nanometer size; (ii)thermoresponsive behavior: thermally triggered drug release; (iii) disulfides in their structure: mucoadhesive trigger upon the mucosal environment; (iv) modulated positive charge which will improve their penetration into bacteria biofilms. Several polymers and crosslinker agents will be evaluated to obtain a series of NGs. Defensin 5 and ceftiofur will be studied as antimicrobial agents to entrap into NGs. The virulence mechanisms developed by bacteria are the main responsible for the failure of antimicrobial treatments. Therefore, NGs will be studied and characterized to find suitable nanocarriers with the ability to penetrate bacterial biofilms and internalize host cells, blocking the virulence mechanisms developed by pathogens. Also, the smart drug release lets ensure that the exposition of the host to antimicrobial will be minimum and necessary to kill bacteria. This fact contributes to reducing bacterial resistance development. Nanotechnology in BM treatment is poorly explored which highlight the novelty of the research project proposed.
Оригинален текст от CORDIS (на английски).
Участници
- UNIVERSIDAD DEL PAIS VASCO/ EUSKAL HERRIKO UNIBERTSITATEA · LeioaКоординаторИспания
Връзки
Данни: CORDIS, © Европейски съюз
